SPITALERI, ANDREA

SPITALERI, ANDREA  

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale  

Mostra records
Risultati 1 - 20 di 66 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Genetic barriers more than environmental associations explain Serratia marcescens population structure 2024 Sterzi, LodovicoNodari, RiccardoSpitaleri, AndreaPapaleo, StellaPanelli, SimonaRimoldi, Sara GiordanaZuccotti, GianvincenzoBandi, ClaudioComandatore, Francesco + Article (author) -
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach 2024 Spitaleri, Andrea + Article (author) -
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL 2024 Spitaleri, AndreaVilla, Simone + Article (author) -
PEI‐Engineered Lipid@PLGA Hybrid Nanoparticles for Multimodal Delivery of Antigens and Immune Adjuvants to the Respiratory Mucosa 2024 Silvestri, TeresaSpitaleri, AndreaBrocca, PaolaItaliani, Paola + Article (author) -
Resistance patterns and transmission of mono- and polyresistant TB: clinical impact of WGS 2023 Spitaleri, Andrea + Article (author) -
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis 2023 Spitaleri, Andrea + Article (author) -
Genomics and the “-Omics” 2023 Spitaleri, Andrea + Book Part (author) -
Advantages of long- and short-reads sequencing for the hybrid investigation of the Mycobacterium tuberculosis genome 2023 Spitaleri, Andrea + Article (author) -
Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005–2020 2022 Spitaleri A. + Article (author) -
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment 2022 Spitaleri A. + Article (author) -
The aminoglycoside-modifying enzyme Eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in Mycobacterium abscessus complex 2022 Spitaleri A. + Article (author) -
Rapid SARS-CoV-2 Intra-Host and Within-Household Emergence of Novel Haplotypes 2022 Spitaleri A. + Article (author) -
Anti-tuberculosis drug resistance in Slovakia, 2018–2019: The first whole-genome epidemiological study 2022 Spitaleri, Andrea + Article (author) -
A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution plates 2022 Andrea, Spitaleri + Article (author) -
Whole Genome Sequencing of Bulgarian Rifampicin Resistant Mycobacterium tuberculosis Strains 2022 Spitaleri A. + Article (author) -
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region 2022 Spitaleri A. + Article (author) -
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis 2022 Spitaleri A. + Article (author) -
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 2022 Lai A.Bergna A.Galli M.Zehender G.Spitaleri A. + Article (author) -
Epidemiological cutoff values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis 2022 Spitaleri A. + Article (author) -
Detection of NDM-1/5 and OXA-48 co-producing extensively drug-resistant hypervirulent Klebsiella pneumoniae in Northern Italy 2022 Spitaleri A. + Article (author) -